(Q50481019)

14 March 2018

title

Hallucination focused integrative treatment improves quality of life in schizophrenia patients. (English)

1 reference

14 March 2018

0 references

1 reference

1 reference

Wiersma D

1

1 reference

14 March 2018

Jenner JA

series ordinal

2

1 reference

14 March 2018

Nienhuis FJ

series ordinal

3

1 reference

14 March 2018

van de Willige G

series ordinal

4

1 reference

14 March 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

14 March 2018

Acta Psychiatrica Scandinavica

published in

1 reference

14 March 2018

volume

109

1 reference

14 March 2018

issue

3

1 reference

14 March 2018

page(s)

194-201

1 reference

14 March 2018

Role of psychosocial treatments in management of schizophrenia: a meta-analytic review of controlled outcome studies

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Cognitive behavioural therapy for drug-resistant psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Cognitive therapy for psychosis in schizophrenia: an effect size analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Cognitive behavioral psychotherapy for schizophrenia: a review of recent empirical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

The psychosocial treatment of schizophrenia: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Compliance therapy in psychotic patients: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Quality of life in patients with schizophrenia in five European countries: the EPSILON study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Cognitive behaviour therapy with coping training for persistent auditory hallucinations in schizophrenia: a naturalistic follow-up study of the durability of effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

The impact of psychiatric disorders on work loss days.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0001-690X.2003.00237.X

10.1046/J.0001-690X.2003.00237.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

1 reference

14 March 2018